I think there was a fair hint of the discrepancy in sales expectations in the latest announcement. Contracts/agreements they thought would be locked away have dragged out and the sales wont flow through until FY2019.
Mr. Sharman said “...Both the USA and Europe respiratory device businesses will still deliver good sales growth, but some delays in key contracts and partnership agreements have impacted our initial growth rate expectations. MVP remains confident in the future growth prospects for Penthrox and our respiratory device business.”
Grateful I was able to get a good entry price on the back of the weak news, been watching this stock run from $4.50 last year.
Ann: Trading Update, page-43
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.020(4.26%) |
Mkt cap ! $42.28M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 51.0¢ | 47.0¢ | $58.40K | 121.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49243 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 999 | 1 |
View Market Depth
| Last trade - 15.58pm 19/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |